Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid) - A double-blind, randomised, multicentre study in adults

Clinical Nutrition

Volumn 32, Issue 2, 2013, Pages 224-231

  Klek, Stanislaw ^a   Chambrier, Cecile ^b   Singer, Pierre ^c   Rubin, Moshe ^c   Bowling, Tim ^d   Staun, Michael ^e   Joly, Francisca ^f   Rasmussen, Henrik ^g   Strauss, Boyd J ^h   Wanten, Geert ⁱ   Smith, Ross ^j   Abraham, Arun ^k   Szczepanek, Kinga ^a   Shaffer, Jon ^k  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b CROIX ROUSSE HOSPITAL   (France)

^c RABIN MEDICAL CENTER   (Israel)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e Rigshospitalet   (Denmark)

^f BEAUJON HOSPITAL   (France)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

^h MONASH UNIVERSITY   (Australia)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j North Shore Private Hospital   (Australia)

^k SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

Lipid emulsions; Liver function; Long term intestinal failure; Parenteral nutrition; Short bowel syndrome; SMOFlipid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; GLYCEROL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; INTRALIPID; LIPID EMULSION; LIPOPROTEIN; MEDIUM CHAIN TRIACYLGLYCEROL; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; SOYBEAN OIL; TUMOR NECROSIS FACTOR RECEPTOR 2;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CATHETER INFECTION; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE; FEMALE; HUMAN; HYPOMAGNESEMIA; INTESTINAL FAILURE; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SIDE EFFECT; SKIN DISEASE; SOFT TISSUE DISEASE; URINARY TRACT INFECTION; VITAL SIGN; VITAMIN BLOOD LEVEL; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-6; FEMALE; FISH OILS; HUMANS; INTERLEUKIN-6; LIVER; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS; PHOSPHOLIPIDS; PLANT OILS; RECEPTORS, TUMOR NECROSIS FACTOR; SOYBEAN OIL; TRIGLYCERIDES; VITAMIN E; YOUNG ADULT;

EID: 84875249213     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.06.011     Document Type: Article

References (43)

1. Goulet O., Joly F., Corriol O., Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 2009, 14:256-261.
2. Schuberth O., Wretlind A. Intravenous infusion of fat emulsions, phosphatides and emulsifying agents. Acta Chir Scand 1961, 278:S1-S21.
3. Carpentier Y.A. Intravascular metabolism of fat emulsions: the Arvid Wretlind Lecture, ESPEN 1988. Clin Nutr 1989, 8:115-125.
4. Mirtallo J.M., Dasta J.F., Kleinschmidt K.C., Varon J. State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications. Ann Pharmacother 2010, 44:688-700.
5. Calder P.C. Hot topics in parenteral nutrition. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc 2009, 68:252-260.
6. Wanten G.J., Calder P.C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007, 85:1171-1184.
7. Waitzberg D.L., Torrinhas R.S., Jacintho T.M. New parenteral lipid emulsions for clinical use. J Parenter Enteral Nutr 2006, 30:351-367.
8. Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R. 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005, 41(Suppl. 2):S1-87.
9. Gentili A., Pigna A., Iannella E., Mondardini M.C., Ceccarelli P.L., Baccarini E., et al. Prolonged neonatal parenteral nutrition with a fat emulsion containing medium-chain triglycerides. Rivista Italiana di Nutrizione Parenteral ed Enterale 2000, 18:134-142.
10. Pitkänen O.M. Parenteral lipids and the preterm infant: between Scylla and Charybdis. Acta Paediatr 2004, 93:1028-1030.
11. Sala-Vila A., Barbosa V.M., Calder P.C. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care 2007, 10:165-174.
12. Mayer K., Gokorsch S., Fegbeutel C., Hattar K., Rosseau S., Walmrath D., et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003, 167:1321-1328.
13. Calder P.C. Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc 2006, 65:264-277.
14. Calder P.C. Rationale and use of n-3 fatty acids in artificial nutrition. Proc Nutr Soc 2010, 69:565-573.
15. Braga M., Ljungqvist O., Soeters P., Fearon K., Weimann A., Bozzetti F. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr 2009, 28:378-386.
16. Singer P., Berger M.M., Van den Berghe G., Biolo G., Calder P., Forbes A., et al. ESPEN. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28:387-400.
17. Mertes N., Grimm H., Furst P., Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006, 50:253-259.
18. Skouroliakou M., Konstantinou D., Koutri K., Kakavelaki C., Stathopoulou M., Antoniadi M., et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr 2010.
19. Tomsits E., Pataki M., Tolgyesi A., Fekete G., Rischak K., Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010.
20. Antebi H., Mansoor O., Ferrier C., Tetegan M., Morvan C., Rangaraj J., et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. J Parenter Enteral Nutr 2004, 28:142-148.
21. Piper S.N., Schade I., Beschmann R.B., Maleck W.H., Boldt J., Rohm K.D. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol 2009, 26:1076-1082.
22. Goulet O., Antebi H., Wolf C., Talbotec C., Alcindor L.G., Corriol O., et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. J Parenter Enteral Nutr 2010, 34:485-495.
23. Anish A, Lawson A, Cram H, Maddison K, Cunningham S, Torrence A, Thomas JE. SMOFlipid in intestinal failure associated liver disease - experience in a regional centre. 2010; Abstracts from the Paediatric Research Society Autumn Meeting 2009 Newcastle upon Tyne 16th and 17th November.
24. Rafeeq M., Bremner R., Davies P., Protheroe S., Holden C., Johnson T., et al. A sudden and marked reduction in PN cholestasis on changing from a conventional intravenous lipid source to SMOFlipid. J Pediatr Gastroenterol Nutr 2009, 48(Suppl. 3). E140.
25. Common Terminology Criteria for Adverse Events (CTCAE) classification v 3.0, http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.
26. Buchman A.L., Iyer K., Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006, 43:9-19.
27. Mayer K., Schaefer M.B., Seeger W. Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006, 9:140-148.
28. Grimm H., Mertes N., Goeters C., Schlotzer E., Mayer K., Grimminger F., et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 2006, 45:55-60.
29. Fürst P., Kuhn K.S. Fish oil emulsions: what benefits can they bring?. Clin Nutr 2000, 19:7-14.
30. Rayyan M., Allegaert K., Ott B., Fusch C., Jochum F., Devlieger H. A randomised, double-blind study evaluating the safety, tolerability and efficacy of SMOF 20% compared to Intralipid 20% in premature infants. J Ped Gastroenterol Nutr 2007, 44:e314.
31. Diamond I.R., Sterescu A., Pencharz P.B., Kim J.H., Wales P.W. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009, 48:209-215.
32. Gura K.M., Duggan C.P., Collier S.B., Jennings R.W., Folkman J., Bistrian B.R., et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006, 118:e197-e201.
33. Gura K.M., Lee S., Valim C., Zhou J., Kim S., Modi B.P., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008, 121:e678-e686.
34. Ekema G., Falchetti D., Boroni G., Tanca A.R., Altana C., Righetti L., et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). J Pediatr Surg 2008, 43:1191-1195.
35. Diamond I.R., Pencharz P.B., Wales P.W. Omega-3 lipids for intestinal failure associated liver disease. Semin Pediatr Surg 2009, 18:239-245.
36. Diamond I.R., Sterescu A., Pencharz P.B., Wales P.W. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int 2008, 24:773-778.
37. Heller A.R., Rossel T., Gottschlich B., Tiebel O., Menschikowski M., Litz R.J., et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004, 111:611-616.
38. Reimund J.M., Rahmi G., Escalin G., Pinna G., Finck G., Muller C.D., et al. Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 2005, 21:445-454.
39. Bouletreau P., Berrada K., Chambrier C. Tolérance hépatique de l'émulsion lipidique ClinOléic. Nutr Clin Metabol 1996, 10:33S-36S.
40. Goulet O., Postaire M., De Potter S., Boya I., Jouniaux A.M., Bereziat G., et al. Medium-chain triglycerides and long-term parenteral nutrition in children. Nutrition 1992, 8:333-337.
41. Goulet O., De Potter S., Antebi H., Driss F., Colomb V., Bereziat G., et al. Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr 1999, 70:338-345.
42. Schade I., Röhm K.D., Schellhaass A., Mengistu A., Boldt J., Piper S.N. Inflammatory response in patients requiring parenteral nutrition: comparison of a new fish oil-containing emulsion (SMOF) versus an olive/soybean oil-based formula. Crit Care 2008, 12. S56-
43. Staun M., Pironi L., Bozzetti F., Baxter J., Forbes A., Joly F., et al. ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009, 28:467-479.